**Chapter 4**

*Muscular Dystrophies*

2003;**13**:813-821

2018;**5**(3):279-294

2015;**5**(1):42-50

[48] Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, et al. Executive dysfunction and avoidant personality trait in myotonic dystrophy [55] Voet N, Bleijenberg G, Hendriks J, et al. Both aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD: An RCT. Neurology. 2014;**83**:1914-1922

[56] Okkersen K, Jimenez-Moreno C, Wenninger S, Daidjf F, Glennon J, Cumming S, et al. cognitive behavioral therapy with optimal graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: A multicenter, single-blind, randomized

trial. The Lancet Neurology.

2018;**17**(8):671-680

type 1 (DM-1) and in proximal myotonic myopathy (PROMM/ DM-2). Neuromuscular Disorders.

[49] Minier L, Lignier B, Bouvet C, Gallais B, Camart N. A review of psychopathology features, personality, and coping in myotonic dystrophy type 1. Journal of Neuromuscular Diseases.

[50] De Carolis A, Cipollini V, Corigliano V, Comparelli A, Sepe-Monti M, Orzi F, et al. Anosognosia in people with cognitive impairment: Association with cognitive deficits and behavioral disturbances. Dementia and Geriatric Cognitive Disorders Extra.

[51] Stuss D. Disturbances of selfawareness after frontal system damage. In: Prigatano GP, Schacter DL, editors. Awareness of Deficit after Brain Injury: Clinical and Theoretical Issues. New York: Oxford Press; 1991. pp. 63-83

[52] Baldanzi S, Bevilacqua F, Lorio R, Volpi L, Simoncini C, Petrucci A, et al. Disease awareness in myotonic dystrophy type 1: An observational cross-sectional study. Orphanet Journal of Rare Diseases. 2016;**11**(34). DOI:

[53] Kalkman JS, Schillings ML, van der Werf SP, et al. Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-1. Journal of Neurology, Neurosurgery, and Psychiatry. 2015;**76**:1406-1409

[54] Heatwole C, Bode R, Johnson N, et al. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology. 2012;**79**:348-357

10.1186/s13023-016-0417-z

**50**
